SEC Form 4Coverage since May 27, 2026
$CYTK insider trading
Over the last 12 months, Cytokinetics insiders reported no purchases and 17 sales totaling $11.7M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $11.7M 17 events
- Events · 12m
- 17 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $CYTK · 12Mvia TradingView
Top insiders · 12m
Blum Robert IPresident & CEO5× · $3.0M
Malik Fady IbrahamEVP Research & Development4× · $1.1M
Callos AndrewEVP, Chief Commercial Officer3× · $3.5M
Lee SungEVP, Chief Financial Officer3× · $3.6M
Kaye Edward M. MD—1× · $223K
All insider trades
17 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Callos AndrewEVP, Chief Commercial Officer · O | ▼ Sale | 14,000 | $79.88 | $1.1M | -19.3% | plan |
| Jul 27, 2026 | Blum Robert IPresident & CEO · O·D | ▼ Sale | 7,500 | $80.87 | $607K | -1.9% | plan |
| Jul 21, 2026 | Malik Fady IbrahamEVP Research & Development · O | ▼ Sale | 3,500 | $80.59 | $282K | -2.2% | plan |
| Jul 13, 2026 | Blum Robert IPresident & CEO · O·D | ▼ Sale | 7,500 | $82.02 | $615K | -1.9% | plan · 2 tranches |
| Jul 7, 2026 | Malik Fady IbrahamEVP Research & Development · O | ▼ Sale | 3,500 | $86.62 | $303K | -2.2% | plan |
| Jul 1, 2026 | Blum Robert IPresident & CEO · O·D | ▼ Sale | 7,500 | $84.92 | $637K | -1.9% | plan |
| Jul 1, 2026 | Callos AndrewEVP, Chief Commercial Officer · O | ▼ Sale | 15,000 | $85.8 | $1.3M | -20.4% | plan |
| Jul 1, 2026 | Lee SungEVP, Chief Financial Officer · O | ▼ Sale | 1,112 | $87.79 | $98K | -1.7% | plan |
| Jun 29, 2026 | Lee SungEVP, Chief Financial Officer · O | ▼ Sale | 3,134 | $85 | $266K | -4.7% | plan |
| Jun 24, 2026 | Lee SungEVP, Chief Financial Officer · O | ▼ Sale | 38,730 | $82.3 | $3.2M | -38% | plan |
| Jun 23, 2026 | Malik Fady IbrahamEVP Research & Development · O | ▼ Sale | 3,500 | $79.51 | $278K | -2.2% | plan |
| Jun 15, 2026 | Blum Robert IPresident & CEO · O·D | ▼ Sale | 7,500 | $70.46 | $528K | -1.9% | plan |
| Jun 9, 2026 | Malik Fady IbrahamEVP Research & Development · O | ▼ Sale | 3,500 | $67.98 | $238K | -2.2% | plan |
| Jun 1, 2026 | Kaye Edward M. MDD | ▼ Sale | 2,933 | $76.09 | $223K | -22.2% | plan |
| Jun 1, 2026 | Callos AndrewEVP, Chief Commercial Officer · O | ▼ Sale | 15,000 | $74.08 | $1.1M | -20.4% | plan |
| Jun 1, 2026 | PARSHALL B LYNNED | ▼ Sale | 5,000 | $74.08 | $370K | -24.1% | plan |
| May 27, 2026 | Blum Robert IPresident & CEO · O·D | ▼ Sale | 7,500 | $77.21 | $579K | -1.9% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CYTK feed.